FDA Inspection 1233962 — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Jiangsu Hengrui Pharmaceuticals Co., Ltd. on Jan 19, 2024 in Lianyungang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lianyungang (China)
Additional details
Sponsor, Contract Research Organization